Azitra, Inc. (AZTR) vs Longeveron Inc. (LGVN)
- Azitra, Inc. AZTR 0.07 0.00%
- Longeveron Inc. LGVN 1.54 −3.14%
Azitra, Inc. and Longeveron Inc. are both Biotechnology companies. Longeveron Inc. is the larger, with a market value of $5.1M against $4.3M — 1.2× the size. Longeveron Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.0×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against −42.7%. Azitra, Inc. has the higher net margin (0.00% vs −1,977.6%) and the higher return on invested capital (−1,272.5% vs −4,549.0%). Across the 17 metrics below, Azitra, Inc. leads on 13 and Longeveron Inc. on 4.
Valuation
Profitability
| Metric | AZTR | LGVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 69.76% | 65.77% |
| Operating margin | 0.00% | (1,992.84%) | 0.00% |
| Net margin | 0.00% | (1,977.59%) | 0.00% |
| Free cash flow margin | 0.00% | (1,755.69%) | 0.00% |
| Return on equity | (256.67%) | (203.61%) | (54.09%) |
| Return on assets | (190.69%) | (145.64%) | (47.78%) |
| Return on invested capital | (1,272.49%) | (4,549.04%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack